The use of interval‐compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor
暂无分享,去创建一个
C. Weldon | A. L. Frazier | K. Janeway | S. Shusterman | J. Mack | K. Marcus | Natalie B Collins | S. DuBois | Kevin Campbell | Elissa Furutani | Brent R. Weil | D. Shulman | Kevin X. Liu | E. Mullen | A. O'Neill | Katie A Greenzang | A. Groves | Jennifer Spidle
[1] J. Blay,et al. Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients. , 2019, Surgical oncology.
[2] A. Pappo,et al. Desmoplastic Small Round Cell Tumor: Long-Term Complications After Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy , 2019, Annals of Surgical Oncology.
[3] H. Lederman,et al. Irinotecan and vincristine for the treatment of refractory desmoplastic small round cell tumor in a developing country: a case report , 2019, Journal of Medical Case Reports.
[4] S. Bielack,et al. Desmoplastic small round cell tumors: Multimodality treatment and new risk factors , 2019, Cancer medicine.
[5] James R. Anderson,et al. The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma , 2018, Cancer.
[6] M. McAleer,et al. Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival , 2018, Clinical Cancer Research.
[7] M. McAleer,et al. Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 Trial , 2018, Annals of Surgical Oncology.
[8] C. Warneke,et al. Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor , 2017, The oncologist.
[9] E. Riedel,et al. A pilot trial of irinotecan, temozolomide and bevacizumab (ITB) for treatment of newly diagnosed patients with desmoplastic small round cell tumor (DSRCT). , 2017 .
[10] J. Blay,et al. Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery? , 2017, PloS one.
[11] B. Dickson,et al. Clinical features and outcomes of 20 patients with abdominopelvic desmoplastic small round cell tumor. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[12] M. Wilcox,et al. Role of cephalosporins in the era of Clostridium difficile infection , 2016, The Journal of antimicrobial chemotherapy.
[13] James R. Anderson,et al. Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] D. Orbach,et al. Role of Adjuvant Radiation Therapy After Surgery for Abdominal Desmoplastic Small Round Cell Tumors. , 2016, International journal of radiation oncology, biology, physics.
[15] A. Ferrari,et al. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005. , 2016, European journal of cancer.
[16] M. McAleer,et al. Survival and toxicity following sequential multimodality treatment including whole abdominopelvic radiotherapy for patients with desmoplastic small round cell tumor. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] R. Goldsby,et al. Clinical Characteristics and Outcomes of Pediatric Patients with Desmoplastic Small Round Cell Tumor , 2016, Rare tumors.
[18] R. Goldsby,et al. Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] S. Sleijfer,et al. Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience , 2014, Clinical Sarcoma Research.
[20] L. Qin,et al. Predictors of overall survival in patients diagnosed with desmoplastic small round cell tumor (DSRCT). , 2014 .
[21] M. McAleer,et al. Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery. , 2012, International journal of radiation oncology, biology, physics.
[22] L. Wexler,et al. Irinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan‐Kettering experience , 2009, Pediatric blood & cancer.
[23] C. Compton,et al. A uniform residual tumor (R) classification , 2009, Cancer.
[24] S. Woo,et al. Outpatient and Home Chemotherapy with Novel Local Control Strategies in Desmoplastic Small Round Cell Tumor , 2008, Sarcoma.
[25] A. Davidoff,et al. The feasibility and outcome of nephron‐sparing surgery for children with bilateral Wilms tumor , 2008, Cancer.
[26] A. Pappo,et al. Reducing irinotecan‐associated diarrhea in children , 2008, Pediatric blood & cancer.
[27] T. Merchant,et al. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high‐risk sarcomas , 2006, Cancer.
[28] P. Houghton,et al. Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] M. Carli,et al. Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma , 2006, Cancer.
[30] A. Huang,et al. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies , 2004, Canadian Medical Association Journal.
[31] K. Goodman,et al. Whole abdominopelvic radiotherapy for desmoplastic small round-cell tumor. , 2002, International journal of radiation oncology, biology, physics.
[32] P. Rosoff,et al. Successful clinical response to irinotecan in desmoplastic round blue cell tumor. , 1999, Medical and pediatric oncology.
[33] W. Gerald,et al. Desmoplastic small round cell tumors: Prognostic indicators and results of surgical management , 1998, Annals of Surgical Oncology.
[34] W. Gerald,et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] W. Gerald,et al. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. , 1994, Cancer research.
[36] K. Goodman,et al. Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience. , 2013, International journal of radiation oncology, biology, physics.
[37] M. LaQuaglia,et al. Characteristic imaging features of desmoplastic small round cell tumour , 2012, Pediatric Radiology.
[38] N. Willich,et al. Late effects of abdominal irradiation in children: a review of the literature. , 2010, Anticancer research.
[39] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.
[40] S. Wolden,et al. Results of multimodal treatment for desmoplastic small round cell tumors. , 2005, Journal of pediatric surgery.